Marc-André Roy

Use of reference markers in the speech of people with schizophrenia spectrum disorders: Evidence from two referential communication tasks manipulating common ground with the interaction partnerpublié le 2025-06

Using a learning health system to integrate Peer Support in Early Intervention Services for psychosis in Quebec: Protocol for a Participatory, Mixed-Methods Study (the PAIRPEP project)publié le 2025-05-16

SARPEP, a rapid-learning healthcare system of early intervention services for psychosis in Quebec, Canada: Feasibility, acceptability and early impactspublié le 2025-03

Validation francophone de la CASIG-rev – un outil clinique visant à soutenir le rétablissement des personnes avec un trouble psychiatrique: French validation of the CASIG-rev – a clinical personal recovery assessment for people with psychiatric disorderspublié le 2024-10

Assessing the fidelity of supported education programs for first‐episode psychosis to the supported employment guidelines adapted for educationpublié le 2024-09

Psychotic Disorders and exosomes: An overview of current evidence and future directionspublié le 2024-09

Effect of Cannabis Legalization in Canada on the Incidence of Psychosis Consultations in Quebec City's Psychiatric Emergency Servicespublié le 2024-08

Risk factors for homelessness and housing instability in the first episode of mental illness: Initial findings from the AMONT studypublié le 2024-07

Assessing the Fidelity of Supported Education Programs for First-Episode Psychosis To the Supported Employment Guidelines Adapted for Educationpublié le 2024-01-30

Evaluating preferences for online psychological interventions to decrease cannabis use in young adults with psychosis: An observational studypublié le 2023-08

Housing trajectories and the risk of homelessness among new mental health service users: Protocol for the AMONT studypublié le 2023-05

Gaming Disorder and Psychotic Disorders: A Scoping Review.publié le 2022-11

Evaluating romantic and sexual functioning among persons with psychosis: Reliability and validity of two measures.publié le 2022-11

Real-life effectiveness of transitioning from paliperidone palmitate 1-monthly to paliperidone palmitate 3-monthly long-acting injectable formulation.publié le 2022-11

The other side of the social interaction: Theory of mind impairments in people with schizophrenia are linked to other people's difficulties in understanding them.publié le 2022-07

A Rapid-Learning Health System to Support Implementation of Early Intervention Services for Psychosis in Quebec, Canada: Protocol.publié le 2022-07

Real-world effectiveness of aripiprazole once-monthly REACT study: Pooled analysis of two noninterventional studies.publié le 2022-07

Multidimensional analysis of adult patients' care trajectories before a first diagnosis of schizophrenia.publié le 2022-05

Clozapine Rechallenge or Continuation Despite Neutropenia, an Extended Follow-up of a Consecutive Quebec Case Series.publié le 2022-05

For a structured response to the psychosocial consequences of the restrictive measures imposed by the global COVID-19 health pandemic: the MAVIPAN longitudinal prospective cohort study protocol.publié le 2022-04

What areas of everyday functioning are affected by theory of mind deficits in recent-onset schizophrenia spectrum disorders? publié le 2022-04

Treating Depression Following Biliopancreatic Diversion With Duodenal Switch Surgery: A Case Report.publié le 2022-03

Comparative effectiveness and safety of antipsychotic drugs in patients with schizophrenia initiating or reinitiating treatment: A Real-World Observational Study.publié le 2022-03

Antipsychotic utilization trajectories three years after initiating or reinitiating treatment of schizophrenia: A state sequence analysis approach.publié le 2022-02

Management of Rhabdomyolysis in a Patient Treated with Clozapine: A Case Report and Clinical Recommendations.publié le 2022-02

A Rapid-Learning Health System to Support Implementation of Early Intervention Services for Psychosis in Quebec, Canada: Protocol (Preprint)publié le 2022-02-18

Association between previous and future antipsychotic adherence in patients initiating clozapine: real-world observational study.publié le 2022-01

A Rapid Learning Health System to Support Implementation of Early Intervention Services for Psychosis in Quebec, Canada: Study Protocolpublié le 2021-12

Urbanicity, Schizophrenia and Equitable Specialist Services Allocation.publié le 2021-09

Clozapine rechallenge following neutropenia using granulocyte colony-stimulating factor: A Quebec case series.publié le 2021-07

A Chart Audit Study of Clozapine Utilization in Early Psychosis.publié le 2021-05

Problem Gambling Associated with Aripiprazole: A Nested Case-Control Study in a First-Episode Psychosis Program.publié le 2021-03

[Family Approaches in Early Intervention: Benchmarks to Guide Intervention and Support Families in First Episode Psychosis Programs (FEPP)].publié le 2021-01

[From Kraepelin to McGorry: Scientific Vision and Experiential Narrative around a Major Paradigmatic Shift].publié le 2021-01

[Early Intervention for Psychosis from Past to Future: Overcoming Implementation Challenges to Maximize its Impact?]publié le 2021-01

Intervenir auprès des jeunes atteints de premier épisode psychotique : un recueil de savoirs et d’expériences en francophonie québécoise.publié le 2021-01

[Detecting and Treating Comorbid Disorders in First-Episode Psychosis: A Lever for Recovery].publié le 2021-01

[Psychopharmacology of First Episode Psychosis: An Approach Based on Recovery].publié le 2021-01

[A Healthy Mind in a Healthy Body: The Value of Physical Activity for Youth With First Episode Psychosis].publié le 2021-01